Deoxypyridinoline (D-Pyrilinks-D, CAS 83462-55-9) is a pyridinium cross-link compound derived from the post-translational modification of collagen. It is a non-reducible trifunctional cross-link formed between two hydroxylysine residues and one lysine residue within the telopeptide region of type I collagen. Structurally, it is a heterocyclic, fluorescent molecule. Its primary and most significant application is as a specific and sensitive biochemical marker for bone resorption. During bone degradation by osteoclasts, D-Pyrilinks-D is released into the bloodstream and excreted in urine. Measurement of its concentration in urine or serum is a standard clinical and research tool for assessing the rate of bone turnover. It is widely used in the diagnosis and monitoring of metabolic bone diseases such as osteoporosis, Paget's disease, and for evaluating the efficacy of anti-resorptive therapies in oncology (e.g., bone metastases) and rheumatology. Due to its critical role as a biomarker, it is produced and standardized as a reference material for immunoassays and high-performance liquid chromatography (HPLC) methods. Its analysis requires specific handling to ensure stability, as it is light-sensitive and can be affected by sample collection and storage conditions.